Stereotaxis Research Development vs Gross Profit Analysis

STXS Stock

USD 2.39 0.16 7.17%

Stereotaxis financial indicator trend analysis is much more than just breaking down Stereotaxis prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stereotaxis is a good investment. Please check the relationship between Stereotaxis Research Development and its Gross Profit accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stereotaxis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Stereotaxis Stock please use our How to Invest in Stereotaxis guide.

Research Development vs Gross Profit

Research Development vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stereotaxis Research Development account and Gross Profit. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Stereotaxis' Research Development and Gross Profit is -0.14. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Stereotaxis, assuming nothing else is changed. The correlation between historical values of Stereotaxis' Research Development and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Stereotaxis are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Research Development i.e., Stereotaxis' Research Development and Gross Profit go up and down completely randomly.

Correlation Coefficient

-0.14

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Stereotaxis minus its cost of goods sold. It is profit before Stereotaxis operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most indicators from Stereotaxis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stereotaxis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stereotaxis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Stereotaxis Stock please use our How to Invest in Stereotaxis guide.Selling General Administrative is likely to drop to about 13.3 M in 2024. Issuance Of Capital Stock is likely to drop to about 110.2 K in 2024

	2021	2022	2023	2024 (projected)
Total Revenue	35.0M	28.1M	26.8M	34.4M
Depreciation And Amortization	105.7K	429K	595K	961.3K

Total Revenue Depreciation And Amortization

Stereotaxis fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Property Plant And Equipment Gross
Total Assets		0.75	-0.23	0.2	-0.16	-0.09	0.62	-0.05	-0.47	-0.18	-0.12	-0.46	-0.25	0.24	0.63	0.0	-0.43	0.44	0.7	-0.24	0.84	0.03	0.67	0.36	0.59	0.59
Total Stockholder Equity	0.75		-0.03	0.42	0.22	0.29	0.74	-0.52	-0.39	-0.77	-0.64	-0.55	-0.73	0.17	0.49	-0.55	-0.84	-0.14	0.81	-0.65	0.94	-0.56	0.64	-0.06	0.03	0.49
Retained Earnings	-0.23	-0.03		0.74	0.92	0.91	-0.64	-0.06	0.03	-0.2	0.11	-0.09	-0.07	-0.57	-0.41	-0.55	0.0	-0.14	0.11	0.13	0.06	-0.22	-0.61	-0.26	-0.15	-0.45
Non Current Assets Total	0.2	0.42	0.74		0.86	0.86	-0.08	-0.17	-0.24	-0.45	-0.2	-0.33	-0.39	-0.16	0.26	-0.6	-0.27	0.04	0.32	-0.21	0.41	-0.42	-0.1	0.08	-0.1	0.2
Non Currrent Assets Other	-0.16	0.22	0.92	0.86		0.99	-0.35	-0.25	-0.01	-0.49	-0.22	-0.18	-0.36	-0.43	-0.21	-0.74	-0.28	-0.31	0.26	-0.15	0.23	-0.53	-0.4	-0.26	-0.35	-0.2
Other Assets	-0.09	0.29	0.91	0.86	0.99		-0.31	-0.29	-0.04	-0.52	-0.25	-0.2	-0.39	-0.43	-0.21	-0.77	-0.33	-0.32	0.32	-0.18	0.31	-0.56	-0.37	-0.27	-0.33	-0.21
Common Stock Shares Outstanding	0.62	0.74	-0.64	-0.08	-0.35	-0.31		-0.4	-0.24	-0.48	-0.59	-0.37	-0.52	0.5	0.72	-0.09	-0.62	-0.05	0.48	-0.65	0.58	-0.32	0.92	0.14	0.05	0.78
Non Current Liabilities Total	-0.05	-0.52	-0.06	-0.17	-0.25	-0.29	-0.4		0.02	0.73	0.87	-0.19	0.31	0.16	-0.02	0.53	0.76	0.49	-0.38	0.93	-0.41	0.72	-0.28	0.47	0.41	-0.07
Other Stockholder Equity	-0.47	-0.39	0.03	-0.24	-0.01	-0.04	-0.24	0.02		0.14	0.13	0.18	0.17	-0.47	-0.36	0.09	0.36	-0.34	-0.47	0.17	-0.44	0.05	-0.19	0.03	-0.35	-0.23
Total Liab	-0.18	-0.77	-0.2	-0.45	-0.49	-0.52	-0.48	0.73	0.14		0.83	0.39	0.86	-0.06	-0.1	0.82	0.83	0.63	-0.54	0.73	-0.59	0.88	-0.28	0.39	0.53	-0.13
Short Long Term Debt Total	-0.12	-0.64	0.11	-0.2	-0.22	-0.25	-0.59	0.87	0.13	0.83		-0.08	0.57	-0.08	-0.23	0.56	0.85	0.57	-0.41	0.92	-0.46	0.85	-0.37	0.35	0.52	-0.28
Other Current Liab	-0.46	-0.55	-0.09	-0.33	-0.18	-0.2	-0.37	-0.19	0.18	0.39	-0.08		0.69	-0.31	-0.31	0.33	0.2	0.01	-0.41	-0.07	-0.47	0.09	-0.4	-0.15	-0.1	-0.3
Total Current Liabilities	-0.25	-0.73	-0.07	-0.39	-0.36	-0.39	-0.52	0.31	0.17	0.86	0.57	0.69		-0.27	-0.22	0.7	0.65	0.53	-0.49	0.4	-0.54	0.68	-0.33	0.19	0.42	-0.25
Other Liab	0.24	0.17	-0.57	-0.16	-0.43	-0.43	0.5	0.16	-0.47	-0.06	-0.08	-0.31	-0.27		0.51	0.21	-0.05	0.11	-0.06	-0.08	0.04	-0.06	0.41	0.36	-0.05	0.45
Property Plant And Equipment Net	0.63	0.49	-0.41	0.26	-0.21	-0.21	0.72	-0.02	-0.36	-0.1	-0.23	-0.31	-0.22	0.51		0.14	-0.2	0.46	0.22	-0.35	0.39	0.0	0.74	0.51	0.31	0.96
Current Deferred Revenue	0.0	-0.55	-0.55	-0.6	-0.74	-0.77	-0.09	0.53	0.09	0.82	0.56	0.33	0.7	0.21	0.14		0.66	0.57	-0.53	0.45	-0.48	0.79	-0.01	0.54	0.52	0.1
Net Debt	-0.43	-0.84	0.0	-0.27	-0.28	-0.33	-0.62	0.76	0.36	0.83	0.85	0.2	0.65	-0.05	-0.2	0.66		0.42	-0.82	0.81	-0.79	0.77	-0.46	0.37	0.26	-0.27
Accounts Payable	0.44	-0.14	-0.14	0.04	-0.31	-0.32	-0.05	0.49	-0.34	0.63	0.57	0.01	0.53	0.11	0.46	0.57	0.42		-0.04	0.35	0.01	0.69	0.22	0.57	0.78	0.35
Cash	0.7	0.81	0.11	0.32	0.26	0.32	0.48	-0.38	-0.47	-0.54	-0.41	-0.41	-0.49	-0.06	0.22	-0.53	-0.82	-0.04		-0.44	0.91	-0.39	0.47	-0.21	0.19	0.28
Long Term Debt	-0.24	-0.65	0.13	-0.21	-0.15	-0.18	-0.65	0.93	0.17	0.73	0.92	-0.07	0.4	-0.08	-0.35	0.45	0.81	0.35	-0.44		-0.51	0.71	-0.52	0.28	0.32	-0.4
Cash And Short Term Investments	0.84	0.94	0.06	0.41	0.23	0.31	0.58	-0.41	-0.44	-0.59	-0.46	-0.47	-0.54	0.04	0.39	-0.48	-0.79	0.01	0.91	-0.51		-0.42	0.55	-0.04	0.22	0.39
Net Receivables	0.03	-0.56	-0.22	-0.42	-0.53	-0.56	-0.32	0.72	0.05	0.88	0.85	0.09	0.68	-0.06	0.0	0.79	0.77	0.69	-0.39	0.71	-0.42		-0.11	0.29	0.75	-0.07
Common Stock Total Equity	0.67	0.64	-0.61	-0.1	-0.4	-0.37	0.92	-0.28	-0.19	-0.28	-0.37	-0.4	-0.33	0.41	0.74	-0.01	-0.46	0.22	0.47	-0.52	0.55	-0.11		0.2	0.21	0.8
Inventory	0.36	-0.06	-0.26	0.08	-0.26	-0.27	0.14	0.47	0.03	0.39	0.35	-0.15	0.19	0.36	0.51	0.54	0.37	0.57	-0.21	0.28	-0.04	0.29	0.2		0.3	0.49
Other Current Assets	0.59	0.03	-0.15	-0.1	-0.35	-0.33	0.05	0.41	-0.35	0.53	0.52	-0.1	0.42	-0.05	0.31	0.52	0.26	0.78	0.19	0.32	0.22	0.75	0.21	0.3		0.24
Property Plant And Equipment Gross	0.59	0.49	-0.45	0.2	-0.2	-0.21	0.78	-0.07	-0.23	-0.13	-0.28	-0.3	-0.25	0.45	0.96	0.1	-0.27	0.35	0.28	-0.4	0.39	-0.07	0.8	0.49	0.24

Click cells to compare fundamentals

Stereotaxis Account Relationship Matchups

Stereotaxis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	43.6M	55.5M	61.0M	53.4M	41.9M	33.6M
Total Stockholder Equity	28.5M	40.2M	39.4M	31.9M	16.3M	10.1M
Retained Earnings	(481.3M)	(488.0M)	(498.7M)	(517.0M)	(537.7M)	(564.6M)
Non Current Assets Total	4.8M	503.6K	9.6M	10.2M	8.6M	4.7M
Non Currrent Assets Other	218.1K	308.5K	278.2K	208K	356K	338.2K
Other Assets	218.1K	2.5M	1.2M	952K	1.0	0.95
Common Stock Shares Outstanding	63.1M	72.7M	75.6M	76.1M	80.7M	84.7M
Liabilities And Stockholders Equity	43.6M	55.5M	61.0M	53.4M	41.9M	33.6M
Non Current Liabilities Total	2.9M	1.7M	8.3M	7.2M	6.7M	9.6M
Other Stockholder Equity	504.0M	522.5M	(5.0B)	543.2M	553.9M	581.6M
Total Liab	15.1M	15.2M	21.6M	21.5M	20.0M	32.1M
Other Current Liab	2.7M	3.0M	2.4M	2.9M	3.0M	5.8M
Total Current Liabilities	12.2M	13.6M	13.3M	14.3M	13.2M	17.1M
Other Liab	809.8K	680.1K	2.5M	1.7M	2.0M	1.1M
Property Plant And Equipment Net	4.5M	195.1K	8.4M	9.2M	8.3M	8.7M
Current Deferred Revenue	5.1M	5.3M	6.3M	7.3M	6.7M	6.9M
Net Debt	(25.8M)	(39.5M)	(32.6M)	(2.7M)	(14.3M)	(13.6M)
Accounts Payable	2.1M	1.6M	4.2M	3.3M	3.2M	2.8M
Cash	30.2M	43.9M	38.7M	8.6M	19.8M	20.7M
Cash And Short Term Investments	30.2M	43.9M	38.7M	28.4M	19.8M	18.2M
Net Receivables	5.3M	3.5M	5.4M	5.1M	3.8M	5.9M
Common Stock Total Equity	68.5K	73.7K	74.6K	75K	86.3K	90.6K
Inventory	1.8M	3.3M	4.4M	7.9M	8.4M	4.3M
Other Current Assets	1.5M	2.0M	2.8M	1.9M	1.2M	1.7M
Property Plant And Equipment Gross	4.5M	2.4M	8.4M	9.2M	12.2M	12.8M
Total Current Assets	38.8M	55.0M	51.4M	43.2M	33.3M	30.2M
Common Stock	68.5K	73.7K	74.6K	75K	81K	43.9K
Property Plant Equipment	250.4K	195.1K	8.4M	3.8M	3.4M	2.2M
Net Tangible Assets	28.5M	40.2M	33.8M	31.9M	36.7M	38.5M
Retained Earnings Total Equity	(481.3M)	(488.0M)	(498.7M)	(517.0M)	(465.3M)	(488.5M)
Capital Surpluse	504.2M	522.7M	532.6M	543.4M	625.0M	508.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Stereotaxis Stock Analysis

When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC